CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Option exercise CEO acquired 20,000 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at $10.60 ($158,973)
- 4 Planned sale General Counsel & Corp Sec sold 1,948 shares at $13.48 ($26,252)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at $11.13 ($166,964)
- 4 Open-market sale Chief Medical Officer sold 653 shares at $10.00 ($6,530)
- 4 Open-market sale Chief Medical Officer sold 55,177 shares at an average $10.06 ($555,267)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 9 of 16 · 305 filings